Crown Electrokinetics Corp. Files S-1 Registration Statement

TL;DR

<b>Crown Electrokinetics Corp. has filed an S-1 registration statement with the SEC, initiating the process for a public offering of securities.</b>

AI Summary

Crown Electrokinetics Corp. (CRKN) filed a IPO Registration (S-1) with the SEC on February 5, 2024. Crown Electrokinetics Corp. filed an S-1 registration statement with the SEC on February 5, 2024. The company is incorporated in Delaware and its fiscal year ends on December 31. Its principal executive offices are located at 1110 NE Circle Blvd, Corvallis, Oregon 97330. Douglas Croxall is listed as the Chief Executive Officer. The filing is for a registration statement under the Securities Act of 1933.

Why It Matters

For investors and stakeholders tracking Crown Electrokinetics Corp., this filing contains several important signals. This S-1 filing indicates Crown Electrokinetics is preparing to raise capital through the public markets, which could fund future growth or operations. The registration statement provides detailed information about the company's business, financial condition, and the securities being offered, allowing potential investors to make informed decisions.

Risk Assessment

Risk Level: medium — Crown Electrokinetics Corp. shows moderate risk based on this filing. The company is filing an S-1, which is a preliminary step for a public offering. The success and terms of this offering are not yet determined, introducing uncertainty regarding future funding and valuation.

Analyst Insight

Monitor the progress of this S-1 filing and any subsequent amendments or prospectuses to understand the terms and timing of Crown Electrokinetics' potential public offering.

Key Numbers

• 2024-02-05 — Filing Date (S-1 Registration Statement filed)
• 333-276875 — SEC File Number (Registration number)
• 1231 — Fiscal Year End (Annual reporting period)

Key Players & Entities

• Crown Electrokinetics Corp. (company) — Registrant name
• Douglas Croxall (person) — Chief Executive Officer
• Pryor Cashman LLP (company) — Legal counsel
• M. Ali Panjwani (person) — Legal counsel
• Delaware (jurisdiction) — State of incorporation
• Corvallis, Oregon (location) — Business address
• February 5, 2024 (date) — Filing date
• 333-276875 (registration_number) — SEC File Number

Forward-Looking Statements

• Crown Electrokinetics Corp. will proceed with an offering of securities to raise capital. (Crown Electrokinetics Corp.) — medium confidence, target: Within 6-12 months of filing
• The offering, if it involves new share issuance, will likely result in some level of share dilution for existing shareholders. (Crown Electrokinetics Corp. shareholders) — high confidence, target: Upon completion of the offering

FAQ

Industry Context

Crown Electrokinetics Corp. operates in the electronic components sector. This S-1 filing is a standard regulatory step for companies intending to offer securities to the public.

Regulatory Implications

The filing is made under the Securities Act of 1933, which governs the registration of new securities offerings in the United States.

What Investors Should Do

1. Review the full S-1 filing for detailed financial statements and business descriptions.
2. Track subsequent SEC filings from Crown Electrokinetics for updates on the offering and company performance.
3. Analyze the company's business model and market position in light of its public offering plans.

Key Dates

• 2024-02-05: S-1 Filing — Registration statement filed with the SEC.

Year-Over-Year Comparison

This is a new S-1 filing, so there is no prior filing of this type to compare against for this specific registration.

Key Financial Figures

• $0.0001 — 0 shares of our common stock, par value $0.0001 per share ("Common Stock"). All share n
• $50,000,000 — that we may sell up to an aggregate of $50,000,000 of our Common Stock to the Selling Stoc
• $4,736,446 — Selling Stockholder, which we have sold $4,736,446 of our Common Stock to the Selling Stoc
• $45,263,554 — receive proceeds of up to an additional $45,263,554 from the sale of the shares of Common S
• $440,000 — Stockholder with an aggregate value of $440,000, which assuming a price of $0.123 per s
• $0.123 — of $440,000, which assuming a price of $0.123 per share (which represents the closing

Filing Documents

• fs12024_crown.htm (S-1) — 2664KB
• fs12024ex5-1_crown.htm (EX-5.1) — 21KB
• fs12024ex23-1_crown.htm (EX-23.1) — 2KB
• fs12024ex-fee_crown.htm (EX-FILING FEES) — 68KB
• timage_001.jpg (GRAPHIC) — 413KB
• timage_002.jpg (GRAPHIC) — 893KB
• timage_003.jpg (GRAPHIC) — 358KB
• ex5-1_001.jpg (GRAPHIC) — 21KB
• ex5-1_002.jpg (GRAPHIC) — 6KB
• 0001213900-24-010111.txt (&nbsp;) — 7531KB
• crkn-20230930.xsd (EX-101.SCH) — 3KB
• crkn-20230930_def.xml (EX-101.DEF) — 6KB
• crkn-20230930_lab.xml (EX-101.LAB) — 8KB
• crkn-20230930_pre.xml (EX-101.PRE) — 6KB
• fs12024_crown_htm.xml (XML) — 1KB

Risk Factors

Risk Factors 19 Special Note Regarding Forward-Looking Statements 40 Committed Equity Financing 42

Use of Proceeds

Use of Proceeds 48 Market for Common Stock and Dividend Policy 49 Capitalization 50

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 52

Description of Securities

Description of Securities 53 Selling Stockholder 61 Plan of Distribution 63 Directors, Executive Officers and Corporate Governance 65

Executive Compensation

Executive Compensation 85 Director Compensation 87 Certain Relationships and Related Transactions 89 Legal Matters 89 Experts 89 Incorporation of Certain Information by Reference 90 Where You Can Find More Information 91 i Table of Contents ABOUT THIS PROSPECTUS The registration statement on Form S -1 of which this prospectus forms a part and that we have filed with the U.S. Securities and Exchange Commission (the "SEC"), includes exhibits that provide more detail of the matters discussed in this prospectus. You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under the heading " Where You Can Find More Information ." You should rely only on the information contained in this prospectus and the related exhibits, any prospectus supplement or amendment thereto, or to which we have referred you, before making your investment decision. Neither we, nor the selling stockholder named herein (the "Selling Stockholder"), nor any financial advisor engaged by us or the Selling Stockholder in connection with this offering, have authorized anyone to provide you with additional information or information different from that contained in this prospectus. Neither the delivery of this prospectus nor the sale of our securities means that the information contained in this prospectus is correct after the date of this prospectus. You should not assume that the information contained in this prospectus, any prospectus supplement or amendments thereto, as well as information we have previously filed with the SEC, is accurate as of any date other than the date on the front cover of the applicable document. Our business, financial condition, results of operations and prospects may have changed since those dates. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The Selling Stockholder is not

View Full Filing

View this S-1 filing on SEC EDGAR